Hi, what are you looking for?
Jewish Business News
Search results for "Copaxone"
Court
– In July, the US Court of Appeals upheld a lower court decision invalidating four patents on the blockbuster MS treatment. – – Reuters...
Business
– Russia’s Federal Antimonopoly Service: Teva’s refusal to supply Copaxone is neither justified economically nor technologically. – Teva’s Copaxone – /By Shiri Habib-Valdhorn and...
Court
– The District Court of the Hague (Netherlands) rejected a patent revocation suit brought by Mylan’s Dutch unit. – – The District Court of...
Business
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
Court
– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through...
empty
– The decision maintains exclusivity for Copaxone until May 24, 2014. – Copaxone/ source : dynamik3d.ca – On Friday, the US Court of Appeals for...
Court
– The Southern District of New York dismissed Teva’s lawsuit against Mylan for the infringement of patents on its MS treatment. – Teva Pharmaceutical...
StartUps
Israel Tech Startups and Innovations: Weekly Roundup October 12 – October 25, 2024 New Startups / VC Funding Israeli Cloud Security Startup Stream.Security Raises...
Business
Teva Pharmaceuticals, a U.S. affiliate of Israel’s Teva Pharmaceutical Industries Ltd., won approval from the U.S. Food and Drug Administration (FDA) for its UZEDY...
Business
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., said that the company has reached a settlement with 48 U.S. states over the...